We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.6B
1-Year Est. Return 109.28%
This Fund
S&P 500
This Quarter Est. Return
+24.06%
1 Year Est. Return
+109.28%
3 Year Est. Return
+327.77%
5 Year Est. Return
+375.26%
10 Year Est. Return
+1,905.03%
AUM
$7.6B
AUM Growth
-$114M
Cap. Flow
+$280M
Cap. Flow %
3.68%
Top 10 Hldgs %
17.53%
Holding
2,785
New
772
Increased
622
Reduced
585
Closed
586

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$51.2M
2
BP icon
BP
BP
+$43.3M
3
DLR icon
Digital Realty Trust
DLR
+$31.4M
4
MMM icon
3M
MMM
+$27.6M
5
SHEL icon
Shell
SHEL
+$26.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 35.54%
2 Healthcare 11.95%
3 Technology 11.57%
4 Industrials 8.74%
5 Consumer Discretionary 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEUP
2076
Neuphoria Therapeutics
NEUP
$19.8M
$61.2K ﹤0.01%
14,000
– –
RZLV
2077
Rezolve AI
RZLV
$909M
$60.2K ﹤0.01%
19,108
– –
IEAGR
2078
Infinite Eagle Acquisition Corp Rights
IEAGR
$58.5K ﹤0.01%
+300,000
New +$57.6K
DMAAR
2079
Drugs Made In America Acquisition Corp Rights
DMAAR
$58.3K ﹤0.01%
529,898
-165,329
-24% -$17.1K
LAB icon
2080
Standard BioTools
LAB
$290M
$58.2K ﹤0.01%
70,760
-1,848
-3% -$1.75K
BREZR
2081
Breeze Acquisition Corp II Right
BREZR
$57.6K ﹤0.01%
+221,707
New +$56.3K
KEEL
2082
CALL
Keel Infrastructure Corp
KEEL
$2.35B
$57.4K ﹤0.01%
+10,000
New +$42.9K
EVAX
2083
Evaxion A/S
EVAX
$30.1M
$57.1K ﹤0.01%
18,426
– –
NOEMR
2084
CO2 Energy Transition Corp Right
NOEMR
$56.7K ﹤0.01%
314,835
– –
CTMX icon
2085
CytomX Therapeutics
CTMX
$588M
$56.3K ﹤0.01%
15,000
– –
SZZLR
2086
Sizzle Acquisition Corp II Right
SZZLR
$56.1K ﹤0.01%
+345,000
New +$64.1K
GIWWR
2087
GigCapital8 Rights
GIWWR
$55.6K ﹤0.01%
213,794
+6,892
+3% +$2.14K
ZOOZW
2088
ZOOZ Strategy Ltd Warrant
ZOOZW
$55.4K ﹤0.01%
10,000
– –
FPH icon
2089
Five Point Holdings
FPH
$341M
$55.1K ﹤0.01%
+10,453
New +$52.4K
BKHAR
2090
Black Hawk Acquisition Corp Rights
BKHAR
$54.5K ﹤0.01%
35,375
– –
KFIIR
2091
K&F Growth Acquisition Corp II Rights
KFIIR
$54.1K ﹤0.01%
432,000
– –
SABR icon
2092
Sabre
SABR
$880M
$54K ﹤0.01%
+25,838
New +$45.3K
PGACR
2093
Pantages Capital Acquisition Corp Right
PGACR
$53.9K ﹤0.01%
264,000
– –
IBACR
2094
IB Acquisition Corp Right
IBACR
$53.2K ﹤0.01%
462,793
-94
-0% -$11
GENVR
2095
Gen Digital Inc Contingent Value Rights
GENVR
$52.9K ﹤0.01%
41,838
– –
KRMD icon
2096
KORU Medical Systems
KRMD
$148M
$52.4K ﹤0.01%
12,467
-25,872
-67% -$106K
VIVO
2097
CALL
VivoPower PLC
VIVO
$132M
$51.7K ﹤0.01%
+10,000
New +$41.3K
ECXWW
2098
ECARX Holdings Warrants
ECXWW
$51.4K ﹤0.01%
39,823
– –
ACCO icon
2099
Acco Brands
ACCO
$398M
$51.1K ﹤0.01%
+12,290
New +$45.1K
HNST icon
2100
The Honest Company
HNST
$568M
$50.7K ﹤0.01%
+13,841
New +$46.7K

Similar funds

Boothbay Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, Boothbay Fund Management held 2,785 positions worth $7.6B, down 1.5% from $7.71B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boothbay Fund Management deployed $280M of net new capital in Q2 2026, opening 772 new positions and adding to 622 existing holdings. Its largest new stake was BP: 986,363 shares worth $36.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 48% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Seagate, an estimated $38.9M trimmed.

  • Boothbay Fund Management's largest Q2 2026 buy was BP: 986,363 shares worth $36.4M.
  • Boothbay Fund Management added most to American Tower in Q2 2026, an estimated $51.2M increase.
  • Boothbay Fund Management's biggest Q2 2026 reduction was Seagate, cutting an estimated $38.9M.
  • Boothbay Fund Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $25.6M.
  • Boothbay Fund Management's ten largest holdings make up 18% of its $7.6B portfolio in Q2 2026.
  • Boothbay Fund Management opened 772 new positions and closed 586 in Q2 2026.
  • Boothbay Fund Management's portfolio value fell 1.5% quarter-over-quarter to $7.6B.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.